上海勁馬實驗設備有限公司作者
勁馬產品文獻:小鼠白介素1β (IL-1β)、(TNF-α)ELISA試劑盒引用文獻
資料類型 | pdf文件 | 資料大小 | 1879765 |
下載次數 | 0 | 資料圖片 | 【點擊查看】 |
上 傳 人 | 上海勁馬實驗設備有限公司 | 需要積分 | 0 |
關 鍵 詞 | 勁馬產品文獻:小鼠白介素1β (IL-1β)、(TNF-α)ELISA試劑盒引用文獻 |
- 【資料簡介】
【文獻標題】Crocetin Downregulates the Proinflammatory Cytokines in Methylcholanthrene-Induced Rodent Tumor Model and Inhibits COX-2 Expression in Cervical Cancer Cells
【作者】Bing Chen, Zhao-Hui Hou, Zhe Dong,et.al
【作者單位】Air Force General Hospital(空軍總醫院)
【文獻中引用產品】
小鼠白介素1β (IL-1β)ELISA試劑盒
小鼠腫瘤壞死因子α(TNF-α)ELISA試劑盒
【關鍵詞】
【DOI】doi.org/10.1155/2015/829513
【影響因子(IF)】3.24
【出版期刊】《Biomed Research International》
【產品原文引用】
Measurement of IL-1β and TNF-α Level. The concentration of IL-1β and TNF-α was determined using a commercial ELISA kit (Shanghai Jinma Biological Technology, Inc.,China) following the manufacturer’s instruction.
Assessment of iNOS Protein Histochemistry. The tumors were dissected free from soft tissues at the end of the study and collected on chrome gel subbed slides. Tissue sections were fixed in 50% acetone in phosphate-buffered saline for 3 minutes at room temperature and endogenous peroxidase activity was blocked by 1.5% H2O2 in methanol for 15 minutes. The iNOS protein was determined using a commercial ELISA kit (Shanghai Jinma Biological Technology, Inc.,China) following the manufacturer’s instruction.
Crocetin Inhibited COX-2 Production in HeLa Cells. Analysis of COX-2 production was performed using an ELISA kit according to manufacturer’s instructions (Shanghai Jinma Biological Technology, Inc., China). HeLa cells were treated with various concentrations of crocetin (1, 10, 50, and100 mol/L) for 24 h. Cell culture supernatants were collected to measure the concentration of COX-2. Production of COX-2 was normalized to protein concentrations.
完整版PDF文獻請咨詢在線客服或者聯系我司業務員!
更多公司福利請關注“上海勁馬”微信公眾號!
- 凡本網注明"來源:環保在線"的所有作品,版權均屬于環保在線,轉載請必須注明環保在線,http://www.gzuyi.com。違反者本網將追究相關法律責任。
- 企業發布的公司新聞、技術文章、資料下載等內容,如涉及侵權、違規遭投訴的,一律由發布企業自行承擔責任,本網有權刪除內容并追溯責任。
- 本網轉載并注明自其它來源的作品,目的在于傳遞更多信息,并不代表本網贊同其觀點或證實其內容的真實性,不承擔此類作品侵權行為的直接責任及連帶責任。其他媒體、網站或個人從本網轉載時,必須保留本網注明的作品來源,并自負版權等法律責任。
- 如涉及作品內容、版權等問題,請在作品發表之日起一周內與本網聯系,否則視為放棄相關權利。